Eus-Pancreaticogastrostomy in a Patient with Subtotal Gastrectomy and Roux-En-Y Reconstruction
Journal Title: Pancreas – Open Journal - Year 2016, Vol 1, Issue 1
Abstract
Chronic Pancreatitis (CP) is often associated with pain due to pancreatic duct obstruction. In these patients, surgical drainage was more effective than endoscopic treatment, achieving a faster, effective, and sustained pain relief.1 However, when surgery is not suitable, different endoscopic procedures could be performed. Endoscopic drainage usually requires transpapillary access to the pancreatic duct during Endoscopic Retrograde Cholangio-Pancreatography (ERCP). The main limitation of endoscopic procedure is that the pancreatic duct could not be accessible at ERCP because of Roux-en-Y reconstruction after gastric-pancreatic surgery. Interventional Endoscopic Ultrasound (EUS) may allow a successful drainage of a dilated pancreatic duct, by using an endoscopic cysto-enterostomy followed by stent placement. We described the EUS-pancreaticogastrostomy performed in a patient who underwent a subtotal gastrectomy complaining with chronic pancreatitis.
Authors and Affiliations
Dioscoridi Lorenzo
Keywords
Related Articles
- EP ID EP556425
- DOI 10.17140/POJ-1-102
- Views 171
- Downloads 0
β-cell Heterogeneity: The Key to β-cell Replacement Therapy
Cellular heterogeneity is crucial for organisms to adapt to their environmental changes. It provides the morphological, functional and molecular diversity that allows tissues and organs to respond to stressors and mainta...
The Enigma of Type 3c Diabetes in Chronic Pancreatitis
Pancreatogenic or Type 3c diabetes (T3cDM) is relatively a new entry in the complex world of diabetes study. While the general population and physicians are well aware of type 1 and type 2 diabetes mellitus, as evidenced...
Evaluation of the Best Power Setting of Laser Waves in Pancreatic Surgery: ECHO ND-YAG Laser Ablation on Bovine Pancreatic Tissue
Background: Pancreatic surgery is one of the most difficult and life-threatening surgical therapy especially during necrotizing pancreatitis and advanced solid neoplasms. Aim of the study: To evaluate the possibility to...
PD-1/PD-L1 Blockade: A New Promising Therapy for the Treatment of Pancreatic Cancer?
Programmed cell death protein 1 (PD-1), a member of the CD28 family, is an immune-checkpoint receptor expressed on a variety of immune cells, such as T-cells, monocytes, B-cells, dendritic cells, and tumor-infiltrating l...
Effects of Obesity and Diabetes on Beta-Cell Mass in Japanese
The prevalence of type 2 diabetes mellitus (T2DM) continues to increase all over the world. T2DM is characterized by insulin resistance and β-cell dysfunction. Recent studies have shown that β-cell dysfunction, but not i...